Keywords: Hepatobiliary, Radiomics
Motivation: To the best of our knowledge, our study is the first to non-invasively assess methyltransferase-like 3 (METTL3) expression in hepatocellular carcinoma (HCC) using multi-sequence MRI-based radiomics.
Goal(s): To develop a multi-region radiomics-based predictive model using multi-sequence MRI to assess METTL3 expression in HCC.
Approach: Three Models (Tumor, Tumor-Expand5, Tumor-Expand10) were constructed and evaluated.
Results: The Tumor-Expand5 model showed the highest efficacy with an AUC of 0.71 in the test set, outperforming both the Tumor and Tumor-Expand10 models. Multi-sequence MRI-based radiomics models hold the potential for preoperatively assessing METTL3 expression in HCC, aiding clinical decision-making.
Impact: This study introduces a novel multi-region radiomics-based model for predicting METTL3 expression in HCC using multi-sequence MRI. The results demonstrate the potential of radiomics, with an emphasis on the Tumor-Expand5 model, highlighting its promise for enhancing clinical decision-making in HCC.
How to access this content:
For one year after publication, abstracts and videos are only open to registrants of this annual meeting. Registrants should use their existing login information. Non-registrant access can be purchased via the ISMRM E-Library.
After one year, current ISMRM & ISMRT members get free access to both the abstracts and videos. Non-members and non-registrants must purchase access via the ISMRM E-Library.
After two years, the meeting proceedings (abstracts) are opened to the public and require no login information. Videos remain behind password for access by members, registrants and E-Library customers.
Keywords